Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

After the commissioning of new oral anticoagulants for the treatment and prevention of thrombosis, these medications are now widely used within clinical settings. Increasing numbers of patients present to the health services on anticoagulant medications, and it is therefore imperative for surgeons to be aware of the new therapeutic treatments available and how patients will benefit from such interventions. This review highlights the most pertinent learning points for surgeons regarding the indications, pharmacokinetics, and perioperative management of these new oral medications, as a quick reference guide.

Original publication




Journal article


J Vasc Surg

Publication Date





1653 - 1657


Administration, Oral, Anticoagulants, Blood Coagulation, Blood Coagulation Tests, Drug Monitoring, Drug Substitution, Fibrinolytic Agents, Hemorrhage, Humans, Patient Selection, Risk Assessment, Risk Factors, Stroke, Thrombosis, Treatment Outcome